Alcon AG | ALC - Selling And Administration Expenses



Alcon AG reported $870M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
AstraZeneca USD 5.01B 1.42B Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Essilor EUR 1.09B 2.08B Jun/2025
Fresenius EUR 740M 97M Jun/2025
Fresenius Medical Care EUR 792M 41M Jun/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
GRIFOLS EUR 282.76M 41.9M Jun/2025
Merck EUR 1.48B 9M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Philips EUR 1.24B 9M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sanofi EUR 2.63B 408M Jun/2025
Smith & Nephew USD 1.42B 77.8M Jun/2025
Sonova Holding CHF 879.9M 48.8M Sep/2024
UCB EUR 1.29B 221M Dec/2024